Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term cytotoxicity. Found 27 abstracts

no pagination
Burns KE, Hensley H, Robinson MK, Thevenin D. Therapeutic Efficacy of a Family of pHLIP-MMAF Conjugates in Cancer Cells and Mouse Models. Molecular pharmaceutics. 2017 Feb 06;14(2):415-22.   PMCID: PMC5293657
Burns KE, Hensley H, Robinson MK, Thevenin D. Therapeutic Efficacy of a Family of pHLIP-MMAF Conjugates in Cancer Cells and Mouse Models. Molecular pharmaceutics. 2017 Jan 13;.
Pazina T, Shemesh A, Brusilovsky M, Porgador A, Campbell KS. Regulation of the Functions of Natural Cytotoxicity Receptors by Interactions with Diverse Ligands and Alterations in Splice Variant Expression. Frontiers in immunology. 2017 Mar;8:369.   PMCID: PMC5371597
Burns KE, Robinson MK, Thevenin D. Inhibition of cancer cell proliferation and breast tumor targeting of pHLIP-monomethyl auristatin E conjugates. Molecular pharmaceutics. 2015 Apr 06;12(4):1250-8.   PMCID: PMC4476257
Barrero CA, Perez-Leal O, Aksoy M, Moncada C, Ji R, Lopez Y, Mallilankaraman K, Madesh M, Criner GJ, Kelsen SG, Merali S. Histone 3.3 Participates in a Self-Sustaining Cascade of Apoptosis That Contributes to the Progression of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2013 Sep;188(6):673-83.   PMCID: PMC3826185
Amoroso AR, Alpaugh RK, Barth MW, McCall AM, Weiner LM. Production and characterization of mice transgenic for the A and B isoforms of human Fc gamma RIII. Cancer Immunology Immunotherapy. 1999 Nov;48(8):443-55.
Alpaugh RK, von Mehren M, Palazzo I, Atkins MB, Sparano JA, Schuchter L, Weiner LM, Dutcher JP. Phase IB trial for malignant melanoma using R24 monoclonal antibody, interleukin-2/alpha-interferon. Medical Oncology. 1998 Sep;15(3):191-8.
Joseph P, Jaiswal AK. NAD(P)H : Quinone oxidoreductase 1 reduces the mutagenicity of DNA caused by NADPH : P450 reductase-activated metabolites of benzo(a)pyrene quinones. British Journal of Cancer. 1998 Mar;77(5):709-19.
Johnson SW, Laub PB, Beesley JS, Ozols RF, Hamilton TC. Increased platinum-DNA damage tolerance is associated with cisplatin resistance and cross-resistance to various chemotherapeutic agents in unrelated human ovarian cancer cell lines. Cancer Research. 1997 Mar;57(5):850-6.
Wang JF, Engelsberg BN, Johnson SW, Witmer C, Merrick WC, Rozmiarek H, Billings PC. DNA binding activity of the mammalian translation elongation complex: Recognition of chromium- and transplatin-damaged DNA. Archives of Toxicology. 1997 May;71(7):450-4.
Yao KS, Hageboutros A, Ford P, Odwyer PJ. Involvement of activator protein-1 and nuclear factor-kappa B transcription factors in the control of the DT-diaphorase expression induced by mitomycin C treatment. Molecular Pharmacology. 1997 Mar;51(3):422-30.
Amoroso AR, Clark JI, Litwin S, HsiehMa S, Shi T, Alpaugh RK, Adams GP, Wolf EJ, Ring DB, Weiner LM. Binding characteristics and antitumor properties of 1A10 bispecific antibody recognizing gp40 and human transferrin receptor. Cancer Research. 1996 Jan;56(1):113-20.
Johnson SW, Shen DW, Pastan I, Gottesman MM, Hamilton TC. Cross-resistance, cisplatin accumulation, and platinum-DNA adduct formation and removal in cisplatin-sensitive and - resistant human hepatoma cell lines. Experimental Cell Research. 1996 Jul 10;226(1):133-9.
Tew KD, Monks A, Barone L, Rosser D, Akerman G, Montali JA, Wheatley JB, Schmidt DE. Glutathione-associated enzymes in the human cell lines of the national cancer institute drug screening program. Molecular Pharmacology. 1996 Jul;50(1):149-59.
Goldberg MR, Heimbrook DC, Russo P, Sarosdy MF, Greenberg RE, Giantonio BJ, Linehan WM, Walther M, Fisher HA, Messing E, Crawford ED, Oliff AI, Pastan IH. Phase-I Clinical-Study of the Recombinant Oncotoxin Tp40 in Superficial Bladder-Cancer. Clinical Cancer Research. 1995 Jan;1(1):57-61.
Perez RP, Johnson SW, Handel LM, Odwyer PJ, Hamilton TC. Determinants of Cisplatin Sensitivity in Normal Versus Spontaneously Transformed Rat Ovarian Surface Epithelial-Cells. Gynecologic Oncology. 1995 Sep;58(3):312-8.
Smith CD, Zilfou JT, Zhang XQ, Hudes GR, Tew KD. Modulation of P-Glycoprotein Activity by Estramustine Is Limited by Binding to Plasma-Proteins. Cancer. 1995 May 15;75(10):2597-604.
Weiner LM, Clark JI, Davey M, Li WS, Depalazzo IG, Ring DB, Alpaugh RK. Phase-I Trial of 2b1, a Bispecific Monoclonal-Antibody Targeting C-Erbb-2 and Fc-Gamma-Riii. Cancer Research. 1995 Oct 15;55(20):4586-93.
Yao KS, Godwin AK, Johnson SW, Ozols RF, Odwyer PJ, Hamilton TC. Evidence for Altered Regulation of Gamma-Glutamylcysteine Synthetase Gene-Expression among Cisplatin-Sensitive and Cisplatin-Resistant Human Ovarian-Cancer Cell-Lines. Cancer Research. 1995 Oct;55(19):4367-74.
Odwyer PJ, Moyer JD, Suffness M, Harrison SD, Cysyk R, Hamilton TC, Plowman J. Antitumor-Activity and Biochemical Effects of Aphidicolin Glycinate (Nsc-303812) Alone and in Combination with Cisplatin in-Vivo. Cancer Research. 1994 Feb;54(3):724-9.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term cytotoxicity

cytotoxicity cancer expression glutathione targeted drug delivery gene cells tumor acidity mechanism carcinoma repair hybrid hybridomas enzymes in vivo efficacy l1210 leukemia-cells sequence cis-diamminedichloroplatinum(ii) monomethyl auristatins lymphocytes peptide drug delivery resistance human ovarian-carcinoma protein carcinoma cells Mice drugs bioactivation Cell Proliferation mice cell-lines R24 benzopyrene activation gd3 mechanisms cytokine release Tumor Cell Line human colon Hydrogen-Ion Concentration alpha-IFN salmonella tester strains factor-i mutations cis-diamminedichloroplatinum(ii) accumulation benzo(a)pyrene-3 dt-diaphorase multiple-drug colony-stimulating factor DNA damage CHROMATIN P450 reductase virus immunity in vivo imaging combination melphalan breast-cancer chronic obstructive pulmonary disease MEDIATORS cyto-toxicity Female LUNG INFLAMMATION human ovarian-cancer adduct formation Critical Care Medicine complexes reverse multidrug-resistance tumor necrosis factor Fluorescence Spectrometry UNFOLDED PROTEIN RESPONSE DEATH 6-quinone peptide mononuclear-cells HISTONES plasma proteins okt3 xanthine dehydrogenase HeLa Cells human bone-marrow t- metabolism placental form cis- natural-killer-cells hypoxia ENDOPLASMIC-RETICULUM STRESS cancer immunology european case-control prostate- interleukin-2 NK cells p-glycoprotein acetylation peripheral-blood lymphocytes reductive activation sequences prospects dna polymerase-alpha cell activation Drug Delivery Systems carcinogenesis mouse ganglioside Respiratory System macrophages monoclonal-antibody NAD(P)H : quinone oxidoreductase 1 lines targeting c- drug-resistance inhibitor transgenic invitro purification Phosphatidylcholines xenograft model induced apoptosis therapy Pharmaceutical Chemistry alpha Circular Dichroism Oligopeptides interferon modulation t-lymphocytes growth invivo growth-factor receptor methods natural cytotoxicity receptors drug accumulation tumors OXIDATIVE INJURY Triple Negative Breast Neoplasms selection ASTHMA dna-binding proteomics COPD Fc receptors pseudomonas exotoxin diamminedichloroplatinum(ii) accumulation erbb-2 Tryptophan bispecific monoclonal-antibody Neoplasm Transplantation EXTRACELLULAR estramustine histone H33 drug resistance t-cells
Last updated on Friday, July 10, 2020